Erowid.org: Erowid Reference 7066 : Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn [Committee on Drugs, American Academy of Pediatrics] : No Author Given

Erowid References Database

No Author Given. “Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn [Committee on Drugs, American Academy of Pediatrics]”. Pediatrics. 2000 Apr 12;105(4Pt1):880-7. <a name="ref">No Author Given.</a> <a href="/references/7066">"Use of psychoactive medication during pregnancy and possible effects on the fetus and newborn [Committee on Drugs, American Academy of Pediatrics]"</a> <i>Pediatrics</i>. 2000 Apr 12;105(4Pt1):880-7.
Text Abstract (this page) Full Text - English (private) Show Articles by No Author Given Article IDs Erowid RefID: 7066 PubMedID: 10742343 Collections Hofmann Collection MDMA Collection All References	Abstract Psychoactive drugs are those psychotherapeutic drugs used to modify emotions and behavior in the treatment of psychiatric illnesses. This statement will limit its scope to drug selection guidelines for those psychoactive agents used during pregnancy for prevention or treatment of the following common psychiatric disorders: schizophrenia, major depression, bipolar disorder, panic disorder, and obsessive-compulsive disorder. The statement assumes that pharmacologic therapy is needed to manage the psychiatric disorder. This decision requires thoughtful psychiatric and obstetric advice.
Comments and Responses to this Article #
Submit Comment

[ Cite HTML ]